TYRA Tyra Biosciences, Inc.
Tyra Biosciences, Inc. (TYRA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 95% planned / 5% discretionary
Largest single sale: $5.0M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| KAPLAN GILLA | Director | Sell | 14,295 | $36.97 | $528.5K | 28,231 −33.6% of holding | |
| Bensen Daniel 2 fills | Chief Discovery Officer | Sell 10b5-1 | 8,000 | $32.87 | $263.0K | 152,853 −5% of holding | |
| Bensen Daniel 2 fills | Chief Discovery Officer | Sell 10b5-1 | 8,000 | $28.52 | $228.2K | 155,998 −4.9% of holding | |
| MORE ROBERT J | Director | Sell 10b5-1 | 10,000 | $25.00 | $250.0K | 3,823,425 −0.3% of holding | |
| Bensen Daniel | Chief Discovery Officer | Sell 10b5-1 | 8,000 | $22.64 | $181.2K | 162,981 −4.7% of holding | |
| MORE ROBERT J | Director | Sell 10b5-1 | 246,871 | $20.25 | $5.0M | 3,833,425 −6.1% of holding | |
| Bensen Daniel | Chief Operating Officer | Sell 10b5-1 | 49,956 | $16.32 | $815.3K | 170,981 −22.6% of holding | |
| Bensen Daniel | Chief Operating Officer | Sell 10b5-1 | 75,633 | $16.07 | $1.2M | 220,937 −25.5% of holding | |
| Bensen Daniel 2 fills | Chief Operating Officer | Sell 10b5-1 | 20,072 | $16.18 | $324.8K | 298,070 −6.3% of holding | |
| Bensen Daniel | Chief Operating Officer | Sell 10b5-1 | 110,228 | $16.02 | $1.8M | 316,642 −25.8% of holding | |
| Bensen Daniel | Chief Operating Officer | Sell 10b5-1 | 1,111 | $16.00 | $17.8K | 426,870 −0.3% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.